An overview of PCI in the very elderly

Journal of Geriatric Cardiology

Volumn 12, Issue 2, 2015, Pages 174-184

  Shanmugam, Vimalraj Bogana ^a   Harper, Richard ^a   Meredith, Ian ^a   Malaiapan, Yuvaraj ^a   Psaltis, Peter J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Acute coronary syndrome; Angina; Antithrombotic therapy; Myocardial infarction; Octogenarians; Percutaneous coronary in tervention; The elderly

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PRASUGREL; TICAGRELOR; WARFARIN;

ACUTE CORONARY SYNDROME; AGED; ANTICOAGULANT THERAPY; BARE METAL STENT; BLEEDING; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; ELDERLY CARE; HUMAN; ISCHEMIC HEART DISEASE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME; VERY ELDERLY;

EID: 84925759527     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.11909/j.issn.1671-5411.2015.02.012     Document Type: Review

References (82)

1. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - 2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Prac-tice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 2002;106:1893-1900.
2. Rajani R, Lindblom M, Dixon G, et al. Evolving trends in percutaneous coronary intervention. Br J Cardiol 2011;18:73-76.
3. Kung HC, Hoyert DL, Xu J, et al. Division of vital statistics. deaths: final data for 2005. National vital statistics reports. Natl Vital Stat Rep 2008;56:1-120.
4. Schneider EL. Aging in the third millennium. Science 1999;283:796-797.
5. Go AS, Mozaffarian D, Roger VL, et al. On behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics - 2013 update: a report from the American Heart Association Circulation 2013;127:e6-e245.
6. Spoon DB, Psaltis PJ, Singh M, et al. Trends in cause of death after percutaneous coronary intervention. Circulation 2014;129:1286-1294.
7. Conrotto F, Scacciatella P, D'Ascenzo F, et al. Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a drug-eluting stent for left main artery registry sub-study). Am J Cardiol 2014;113:2007-2012.
8. Shan L, Saxena A, McMahon R. A systematic review on the quality of life benefits after percutaneous coronary interven-tion in the elderly. Cardiology 2014;129:46-54.
9. Seto TB, Taira DA, Berezin R, et al. Percutaneous coronary revascularization in elderly patients: Impact on functional sta-tus and quality of life. Ann Intern Med 2000;132:955-958.
10. Spertus JA, Salisbury AC, Jones PG, et al. Predictors of qual-ity-of-life benefit after percutaneous coronary intervention. Circulation 2004;110:3789-3794.
11. Kinnaird TD, Stabile E, Mintz GS, et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 2003;92:930-935.
12. Cohen DJ, Lincoff AM, Lavelle TA, et al. Economic evalua-tion of bivalirudin with provisional glycoprotein IIB/IIIA in-hibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial. J Am CollCardiol 2004;44:1792-1800.
13. Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24:1815-1823.
14. Aronow HD, Peyser PA, Eagle KA, et al. Predictors of length of stay after coronary stenting. Am Heart J 2001;142:799-805.
15. Vavalle JP, Rao SV. Impact of bleeding complications on outcomes after percutaneous coronary intervention. Interv Cardiol 2009;1:51-62.
16. Chhatriwalla AK, Amin AP, Kennedy KF, et al. National Cardiovascular Data R. Association between bleeding events and in-hospital mortality after percutaneous coronary inter-vention. JAMA 2013;309:1022-1029.
17. Feldman DN, Gade CL, Slotwinder AJ et al. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (< 60, 60-80, and > 80 years). Am J Car-diol 2006;98:1334-1339.
18. Subherwal S, Bach RG, Chen AY, et al. Baseline risk of ma-jor bleeding in non-ST-segment-elevation myocardial infarc-tion: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early im-plementation of the ACC/AHA Guidelines) Bleeding Score. Circulation 2009;119:1873-1882.
19. Mehran R, Pocock SJ, Nikolsky E, et al. A risk score to pre-dict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol 2010;55:2556-2566.
20. ™. Am J Cardiol 2011;107:1136-1143.
21. Rao SV, Spertus JA, Krone RJ, et al. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention. JACC Cardiol Intv 2013;6:897-904.
22. Rathod K, Knight C. Percutaneous coronary intervention in old age - effective or intrusive? Br J Cardiol 2013;20:6-7.
23. Lockie TPE, Perera D, Webb I, et al. PCI in the elderly: what's the bleeding problem? Heart 2010;96(Suppl 1):S19-S20.
24. Campeau L. Percutaneous radial artery approach for coronary angiography. Cathet Cardiovasc Diagn 1989;16:3-7.
25. Kiemeneij F, Laarman GJ. Percutaneous transradial artery approach for coronary stent implantation. Cathet Cardiovasc Diagn 1993;30:173-178.
26. Cao Z, Zhou YJ, Zhao YX, et al. Transradial approach for coronary angioplasty in Chinese elderly patients. Chin Med J (Engl) 2008;121:1126-1129.
27. Yokoyama N, Takeshita S, Ochiai M, et al. Anatomic varia-tions of the radial artery in patients undergoing transradial coronary intervention. Catheter Cardiovasc Interv 2000;49:357-362.
28. Hsieh V, Jolly SS. Should radial access be the approach of choice for elderly patients? Rev Bras Cardiol Invasiva 2012;20:9-10.
29. Ratib K, Mamas MA, Routledge H, et al. Access site selection for primary PCI: the evidence for transradial access is strong. Heart 2012;98:1392.
30. Chodór P, Krupa H, Kurek T, et al. RADIal versus femoral approach for percutaneous coronary interventions in patients with acute myocardial infarction (RADIAMI): a prospective, randomized, single-center clinical trial. Cardiol J 2009;16:332-340.
31. Saito S, Tanaka S, Hiroe Y, et al. Comparative study on transradial approach vs. transfemoral approach in primary stent implantation for patients with acute myocardial infarc-tion: results of the test for myocardial infarction by prospec-tive unicenter randomization for access sites (TEMPURA) tri-Al. Catheter Cardiovasc Interv 2003;59:26-33.
32. Weaver AN, Henderson RA, Gilchrist IC, et al. Arterial ac-cess and door-to-balloon times for primary percutaneous cor-onary intervention in patients presenting with acute ST-elevation myocardial infarction. Catheter Cardiovasc In-terv 2010;75:695-699.
33. Vink MA, Amoroso G, Dirksen MT, et al. Routine use of the transradial approach in primary percutaneous coronary inter-vention: procedural aspects and outcomes in 2209 patients treated in a single high-volume centre. Heart 2011;97:1938-1942.
34. Mamas MA, Ratib K, Routledge H, et al. Influence of access site selection on PCI-related adverse events in patients with STEMI: meta-Analysis of randomised controlled trials. Heart 2012;98:303-311.
35. Johnman C, Oldroyd KG, Pell JP. Elective percutaneous cor-onary intervention in the elderly patient. Aging Health 2011;7:271-281.
36. Capodanno D, Angiolillo DJ. Antithrombotic therapy in the elderly. J Am Coll Cardiol 2010;56:1683-1692.
37. Wijns W, Kolh P, Danchin N, et al. European Association for Percutaneous Cardiovascular Interventions. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Car-dio-Thoracic Surgery (EACTS). Eur Heart J 2010;31:2501-2555.
38. Murphy NF, Simpson CR, Jhund PS, et al. National survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart 2007;93:606-612.
39. Kushner FG, Hand M, Smith SC, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with STelevation myocardial infarction (updating the 2004 guide-line and 2007 focused update) and ACC/AHA/SCAI guide-lines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009;54:2205-2241.
40. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Associ-Ation Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarc-tion). J Am Coll Cardiol 2007;50:E1-E157.
41. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel ver-sus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-2015.
42. Cannon CP, Harrington RA, James S, et al. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a random-ised double-blind study. Lancet 2010;375:283-293.
43. Parodi G, Antoniucci D, Nikolsky E, et al. Impact of Bival-irudin Therapy in High-Risk Patients With Acute Myocardial Infarction: 1-Year Results From the HORIZONS-AMI (Har-monizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) Trial. JACC Cardiol Interv 2010;3:796-802.
44. Zeymer U, Hof AV, Adgey J, et al. Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMAX trial. Eur Heart J 2014:35:2460-2467.
45. Bittl JA, Strony J, Brinker JA, et al. Angioplasty Study Investigators, et al. Treatment with bivalirudin (Hirulog) as com-pared with heparin during coronary angioplasty for unstable or postinfarction angina. N Engl J Med 1995;333:764-769.
46. Schulz1 S, Mehilli J, Neumann FJ, et al. For the intracoronary stenting and antithrombotic regimen: rapid early action for coronary treatment (ISAR-REACT) 3A trial investigators. ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutane-ous coronary intervention. Eur Heart J 2010;31:2482-2491.
47. Lemesle G, Bonello L, De Labriolle A, et al. Impact of bival-irudin use on in-hospital bleeding and six-months outcomes in octogenarians undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 2009;74:428-435.
48. Lopes RD, Alexander KP, Manoukian SV, et al. Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 2009;53:1021-1030.
49. Cavender MA, Sabatine MS. Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-Analysis of randomised controlled trials. Lancet 2014;384:599.
50. Rao SV, Ohman EM. Anticoagulant therapy for percutaneous coronary intervention. Circ Cardiovas Interv 2010;3:80-88.
51. Guagliumi G, Stone GW, Cox DA, et al. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abcixi-mab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation 2004;110:1598-1604.
52. Ndrepea G, Kastrati A, Mehilli J, et al. Age-dependent effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions. Circulation 2006;114:2040-2046.
53. Hasdai D, Holmes DR Jr., Criger DA, et al. Age and outcome after acute coronary syndromes without persistent ST-segment elevation. Am Heart J 2000;139:858-866.
54. The ESPRIT Investigators. Novel dosing regimen of eptifiba-tide in planned coronary stent implantation (ESPRIT): a randomised, placebo controlled trial. Lancet 2000;356:2037-2044.
55. Platelet Receptor Inhibition in Ischemic Syndrome Manage-ment (PRISM) Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 1998;338:1498-1505.
56. Boersma E, Harrington RA, Moliterno DJ, et al. Platelet gly-coprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-Analysis of all major randomised clinical trials. Lancet 2002;359:189-198.
57. Wennberg DE, Makenka DJ, Sengupta A, et al. Percutaneous transluminal coronary angioplasty in the elderly: epidemiolo-gy, clinical risk factors, and in-hospital outcomes. The North-ern New England Cardiovascular Disease Study Group. Am Heart J 1999;137:639-645.
58. Dynina O, Vakili BA, Slater JN, et al. In-hospital outcomes of contemporary percutaneous coronary interventions in the very elderly. Catheter Cardiovasc Interv 2003;58:351-357.
59. Batchelor WB, Anstrom KJ, Muhlbaier LH, et al. Contempo-rary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7472 octogenarians. Nation-Al Cardiovascular Network Collaboration. J Am Coll Cardiol 2000;36:723-730.
60. Graham MM, Ghali WA, Faris PD, et al. Survival after coro-nary revascularization in the elderly. Circulation 2002;105:2378-2384.
61. Lefevre T, Morice MC, Eltchaninoff H, et al. One-month results of coronary stenting in patients >75 years of age. Am J Cardiol 1998;82:17-21.
62. Achenbach S, Ropers D, Kallert L, et al. Transradial versus transfemoral approach for coronary angiography and interven-tion in patients above 75 years of age. Catheter Cardiovasc Interv 2008;72:629-635.
63. Jaber WA, Lennon RJ, Mathew V, et al. Application of evidence-based medical therapy is associated with improved outcomes after percutaneous coronary intervention and is a valid quality indicator. J Am Coll Cardiol 2005;46:1473-1478.
64. Vlaar PJ, Lennon RJ, Rihal CS, et al. Drug-eluting stents in octogenarians: early and intermediate outcome. Am Heart J 2008;155:680-686.
65. Dangas GD, Singh HS. Primary percutaneous coronary inter-vention in octogenarians: navigate with caution. Heart 2010;96:813-814.
66. Alexander KP, Newby LK, Armstrong PW, et al. Acute cor-onary care in the elderly, part II ST-segment-elevation myo-cardial infarction. A scientific statement for healthcare profes-sionals from the American Heart Association Council on Clinical Cardiology in collaboration with the Society of Geri-Atric Cardiology. Circulation 2007;115:2570-2589.
67. Bueno H, Betriu A, Heras M, et al. Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarc-tion: TRIANA (TRatamiento del InfartoAgudo de miocardi-oeNAncianos) randomized trial and pooled analysis with pre-vious studies. Eur Heart J 2011;32:51-60.
68. Antonsen L, Jensen LO, Terkelsen CJ, et al. Outcomes after primary percutaneous coronary intervention in octogenarians and nonagenarians with ST-segment elevation myocardial in-farction: From the Western Denmark heart registry. Catheter Cardiovasc Interv 2013;81:912-919.
69. Maeng M, Nielsen PH, Busk M, et al. Time to treatment and three-year mortality after primary percutaneous coronary in-tervention for ST-segment elevation myocardial infarction - A DANish trial in acute myocardial infarction-2 (DANAMI-2) substudy. Am J Cardiol 2010;105:1528-1534.
70. Ting HH, Roe MT, Gersh BJ, et al. Factors associated with off-label use of drug-eluting stents in patients with ST-eleva-tion myocardial infarction. Am J Cardiol 2008;101:286-292.
71. López-Palop R, Carrillo P, Frutos A, et al. Safety and efficacy of coronary drug-eluting stents in octogenarians. Rev Esp Cardiol 2009;62:1250-1259.
72. Belder AD, Hernandez JMDLT, Lopez-Palop R, et al. A pro-spective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians. J Am Coll Cardiol 2014;63:1371-1375.
73. De Gregorio J, Kobayashi Y, Albiero R, et al. Coronary artery stenting in the elderly: short-term outcome and long-term an-giographic and clinical follow-up. J Am Coll Cardiol 1998;32:577-583.
74. Lee PY, Alexander KP, Hammill BG, et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001;286:708-713.
75. Yusuf S, Flather M, Pogue J, et al. Variations between coun-tries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators. Lancet 1998;352:507-551.
76. Devlin G, Gore JM, Elliott J, et al. Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The global reg-istry of acute coronary events. Eur Heart J 2008;29:1275-1282.
77. Bach RG, Cannon CP, Weintraub WS, et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syn-dromes. Ann Intern Med 2004;141:186-195.
78. Claude J, Schindler C, Kuster GM, et al. Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease: Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME). Eur Heart J 2004;25:2195-2203.
79. Rana O, Moran R, O'Kane P, et al. Percutaneous coronary intervention in the very elderly (≥ 85 years): trends and out-comes. Br J Cardiol 2013;20:27-31.
80. Grinces C. SENIOR PAMI: a prospective randomized trial of primary angioplasty and thrombolytic therapy in elderly pa-tients with acute myocardial infarction. Presented at: Transcatheter cardiovascular therapeutics 2005: Oct. 19, 2005: Washington, DC, USA.
81. De Boer SP, Barnes EH, Westerhout CM, et al. High-risk patietns with ST.elevation myocardial infarction device greatest absolute benefit from primary percutaneous coronary intervention: results from the primary coronary angioplasty trialist versus thrombolysis (PCAT)-2 collaboration. Am Heart J 2011;161:500-507.
82. Kolte D, Khera S, Palaniswamy C, et al. Early invasive versus initial conservative treatment strategies in octagenarians with UA/STEMI. Am J Med 2013;126:1076-1083.